RA Therapies May Reduce Dementia Risk

Anti-TNF therapies, commonly used to treat the symptoms of rheumatoid arthritis (RA), may potentially reduce the risk of Alzheimers disease. Amyloidosis, a complication of chronic inflammation of RA caused by excess deposits of amyloid proteins in certain organs, can affect the normal function of other organs. Patients with Alzheimers dementia typically have local deposits of a type of amyloid protein in the brain.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access